Fully Human Bifunctional Intrabodies Achieve Graded Reduction of Intracellular Tau and Rescue Survival of MAPT Mutation iPSC-derived Neurons
D'Brant, L.; Rugenstein, N.; Na, S. K.; Miller, M. J.; Czajka, T. F.; Trudeau, N.; Fitz, E. M.; Tomaszek, L.; Fisher, E. S.; Mash, E. S.; Joy, S.; Lotz, S.; Borden, S.; Stevens, K.; Goderie, S.; Wang, Y.; Bertucci, T.; Karch, C. M.; Temple, S.; Butler, D.
Show abstract
Tau protein aggregation is a hallmark of several neurodegenerative diseases, including Alzheimers disease, frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP), spurring development of tau-lowering therapeutic strategies. Here, we report fully human bifunctional anti-tau-PEST intrabodies that bind the mid-domain of tau to block aggregation and degrade tau via the proteasome using the ornithine decarboxylase (ODC) PEST degron. They effectively reduced tau protein in human iPSC-derived cortical neurons in 2D cultures and 3D organoids, including those with the disease-associated tau mutations R5L, N279K, R406W, and V337M. Anti-tau-hPEST intrabodies facilitated efficient ubiquitin-independent proteolysis, in contrast to tau-lowering approaches that rely on the cells ubiquitination system. Importantly, they counteracted the proteasome impairment observed in V337M patient-derived cortical neurons and significantly improved neuronal survival. By serial mutagenesis, we created variants of the PEST degron that achieved graded levels of tau reduction. Moderate reduction was as effective as high reduction against tau V337M-induced neural cell death.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model 95%
- Modeling Alpha-Synuclein Pathology in a Human Brain-Chip to Assess Blood-Brain Barrier Disruption in Parkinson's Disease 94%
- CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro 94%
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
- Human iPSC-derived astrocytes transplanted into the mouse brain display three morphological responses to amyloid-β plaques 93%
- SETD7-mediated lysine monomethylation is abundant on non-hyperphosphorylated nuclear Tau 93%
Similar papers in this journal
- Hypoxia-inducible factor 1 protects neurons from Sarm1-mediated neurodegeneration 94%
- Tau assemblies enter the cytosol in a cholesterol sensitive process essential to seeded aggregation 93%
- Clearing truncated tau protein restores neuronal function and prevents microglia activation in tauopathy mice 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.